New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
The DOI matches its Crossref record; 127 of the 128 references it cites were found in a registry or an index.
Abstract
Poly(ADP-ribose) polymerases (PARPs) are enzymes that transfer ADP-ribose groups to target proteins and thereby affect various nuclear and cytoplasmic processes. The activity of PARP family members, such as PARP1 and PARP2, is tied to cellular signalling pathways, and through poly(ADP-ribosyl)ation (PARylation) they ultimately promote changes in gene expression, RNA and protein abundance, and the location and activity of proteins that mediate signalling responses. PARPs act in a complex response network that is driven by the cellular, molecular and chemical biology of poly(ADP-ribose) (PAR). This PAR-dependent response network is crucial for a broad array of physiological and pathological responses and thus is a good target for chemical therapeutics for several diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated PARP1 will consume NAD+, generating PAR through a process called PARylation82.”
From Mitochondrial and metabolic dysfunction in ageing and age-related diseases (2022) · cites this paper as [82]
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
Poly(ADP-ribose): novel functions for an old molecule
Schreiber, V., Dantzer, F., Ame, J.-C., & de Murcia, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1963 · Cited by 1,915
Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor
Yu, S.-W., Wang, H., Poitras, M. F., Coombs, C., Bowers, W. J., Federoff, H. J., Poirier, G. G., Dawson, T. M., & Dawson, V. L. (2002) · Science · doi:10.1126/science.1072221 · Cited by 1,826
Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
d'AMOURS, D., DESNOYERS, S., d'SILVA, I., & POIRIER, G. G. (1999) · Biochemical Journal · doi:10.1042/bj3420249 · Cited by 1,815
PARP inhibition: PARP1 and beyond
Rouleau, M., Patel, A., Hendzel, M. J., Kaufmann, S. H., & Poirier, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2812 · Cited by 1,298
Gelmon, K. A., Tischkowitz, M., Mackay, H., Swenerton, K., Robidoux, A., Tonkin, K., Hirte, H., Huntsman, D., Clemons, M., Gilks, B., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70214-5 · Cited by 1,117
Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres
Smith, S., Giriat, I., Schmitt, A., & de Lange, T. (1998) · Science · doi:10.1126/science.282.5393.1484 · Cited by 1,012
Cited by
The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
Ray Chaudhuri, A., & Nussenzweig, A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.53 · Cited by 1,786
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
“stress, and metabolism, among other cellular pathways (reviewed in Cantó et al., 2013; Gibson and Kraus, 2012; Kraus and Hottiger, 2013).”
BackgroundInfluentialRegulation of pattern recognition receptor signalling in plants
Couto, D., & Zipfel, C. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.77 · Cited by 1,393
“…target proteins is a common post-translational modification catalysed by PAR polymerases (PARPs) in eukaryotes that regulate important cellular processes, such as DNA repair, gene transcription and chromatin remodelling, particularly during stress, including inflammatory responses in mammals 167 .”
Krokan, H. E., & Bjoras, M. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012583 · Cited by 1,322
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
“…polymer- ase proteins—with PARP1 and PARP2 representing the main PARP activities in mammals—were classically described as DNA repair proteins (Gibson and Kraus, 2012; Schreiber et al., 2006), but recent studies have linked these proteins to metabolism (Asher et al., 2010; Bai et al.,…”
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.137 · Cited by 1,002
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990
Metabolic control of autophagy
Galluzzi, L., Pietrocola, F., Levine, B., & Kroemer, G. (2014) · Cell · doi:10.1016/j.cell.2014.11.006 · Cited by 855
Opportunities and challenges of radiotherapy for treating cancer
Schaue, D., & McBride, W. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.120 · Cited by 784
Systems biology of cisplatin resistance: past, present and future
Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death & Disease · doi:10.1038/cddis.2013.428 · Cited by 782
“to influence the sensitivity of pancreatic and ovarian neoplasms to inhibitors of poly(ADP-ribose) polymerase 1 (PARP1), another important regulator of DNA repair.(144)”
BackgroundWnt/β-catenin signaling in cancers and targeted therapies
Yu, F., Yu, C., Li, F., Zuo, Y., Wang, Y., Yao, L., Wu, C., Wang, C., & Ye, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00701-5 · Cited by 734
“Tankyrase1/2 is a poly (ADP-ribose) polymerase (PARP), attaching PAR chains onto substrates by its catalytic action.(172,173) The enzymes bind and then PARylate Axins, utterly, the Axins are ubiquitylated and degraded.”
BackgroundNsp3 of coronaviruses: Structures and functions of a large multi-domain protein
Lei, J., Kusov, Y., & Hilgenfeld, R. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2017.11.001 · Cited by 727
“For example, PARP7 (ARTD14), PARP10 (ARTD10), PARP12 (ARTD12), and PARP14 (ARTD8) add mono-ADPr to other proteins and themselves (Bütepage et al., 2015), while PARP1 (ARTD1) and PARP2 (ARTD2) add poly(ADPr)s (Gibson and Kraus, 2012).”
PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes
Gupte, R., Liu, Z., & Kraus, W. L. (2017) · Genes & Development · doi:10.1101/gad.291518.116 · Cited by 681
“…(PTM) of proteins resulting in the covalent attachment of a single ADP-ribose unit [i.e., mono(ADP-ribose) (MAR)] or polymers of ADP-ribose units [i.e., poly(ADP-ribose) (PAR)] on a variety of amino acid residues on target proteins (Gibson and Kraus 2012; Daniels et al. 2015a).”
BackgroundSelf-citationMetabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
“Poly(ADP-ribose) polymerases (PARPs) make up a large family of enzymes that catalyze the addition of poly(ADP-ribose)moieties (an NADdependent reaction also known as ADP ribosylation) to multiple substrates, hence regulating a plethora of cellular processes, notably the repair of single and double-strand DNA breaks (1…”
BackgroundPROTACs: great opportunities for academia and industry
Sun, X., Gao, H., Yang, Y., He, M., Wu, Y., Song, Y., Tong, Y., & Rao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0101-6 · Cited by 613
“PARP1 Poly (ADP-ribose) polymerases (PARPs) belongs to DNAdependent nuclear enzymes, which plays the role of transfer negatively charged ADP-ribose moieties from cellular NAD+ to different protein substrates.(280) PARP1 is the most abundant nuclear enzyme of the PARP family.”
BackgroundEssuman, K., Summers, D. W., Sasaki, Y., Mao, X., DiAntonio, A., & Milbrandt, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.022 · Cited by 619
Chromatin Remodeling at DNA Double-Strand Breaks
Price, B. D., & D’Andrea, A. D. (2013) · Cell · doi:10.1016/j.cell.2013.02.011 · Cited by 588
“PARP1 belongs to a family of Parps that play a central role in both transcription and DNA repair (Gibson and Kraus, 2012).”
Poly(ADP-ribose) polymerase inhibition: past, present and future
Curtin, N. J., & Szabo, C. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0076-6 · Cited by 556
Understanding and overcoming resistance to PARP inhibitors in cancer therapy
Dias, M. P., Moser, S. C., Ganesan, S., & Jonkers, J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00532-x · Cited by 505
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins
Alemasova, E. E., & Lavrik, O. I. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz120 · Cited by 497
Genomic landscape of lung adenocarcinoma in East Asians
Chen, J., Yang, H., Teo, A. S. M., Amer, L. B., Sherbaf, F. G., Tan, C. Q., Alvarez, J. J. S., Lu, B., Lim, J. Q., Takano, A., et al. (2020) · Nature Genetics · doi:10.1038/s41588-019-0569-6 · Cited by 509
Regulation of chromatin and gene expression by metabolic enzymes and metabolites
Li, X., Egervari, G., Wang, Y., Berger, S. L., & Lu, Z. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0029-7 · Cited by 491
The Landscape of Targeted Therapies in TNBC
Vagia, E., Mahalingam, D., & Cristofanilli, M. (2020) · Cancers · doi:10.3390/cancers12040916 · Cited by 450
“Upon activation, poly ADP-ribosylation (PARylation) is catalytic for the recruitment of downstream DNA repair effectors such as DNA ligase III, DNA polymerase β, topoisomerases and XRCC1 and the chromatin structure remodeling [34].”
BackgroundZhong, Q., Xiao, X., Qiu, Y., Xu, Z., Chen, C., Chong, B., Zhao, X., Hai, S., Li, S., An, Z., et al. (2023) · MedComm · doi:10.1002/mco2.261 · Cited by 442
McGurk, L., Gomes, E., Guo, L., Mojsilovic-Petrovic, J., Tran, V., Kalb, R. G., Shorter, J., & Bonini, N. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.002 · Cited by 409
“PAR is a negatively charged biopolymer that is covalently attached to target proteins by PAR polymerases (PARPs) (Gibson and Kraus, 2012).”
BackgroundAyrapetov, M. K., Gursoy-Yuzugullu, O., Xu, C., Xu, Y., & Price, B. D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403565111 · Cited by 391
“Because many early responses to DNA damage require poly (ADP-ribose) polymerase (PARP) family members, which catalyze synthesis of PAR chains on the chromatin at DSBs (33), we examined whether the rapid recruitment of kap-1/HP1/suv39h1 to DSBs required PARP activity.”
BackgroundNuclear DNA damage signalling to mitochondria in ageing
Fang, E. F., Scheibye-Knudsen, M., Chua, K. F., Mattson, M. P., Croteau, D. L., & Bohr, V. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.14 · Cited by 387
Gogola, E., Duarte, A. A., de Ruiter, J. R., Wiegant, W. W., Schmid, J. A., de Bruijn, R., James, D. I., Guerrero Llobet, S., Vis, D. J., Annunziato, S., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.008 · Cited by 374
Hong, T., Lei, G., Chen, X., Li, H., Zhang, X., Wu, N., Zhao, Y., Zhang, Y., & Wang, J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101928 · Cited by 373
“Among them, PARP1 is a prototype member with most abundance, serving as a significant target for cancer therapy [1,5,6].”
BackgroundChemical genetic discovery of PARP targets reveals a role for PARP-1 in transcription elongation
Gibson, B. A., Zhang, Y., Jiang, H., Hussey, K. M., Shrimp, J. H., Lin, H., Schwede, F., Yu, Y., & Kraus, W. L. (2016) · Science · doi:10.1126/science.aaf7865 · Cited by 367
Self-citationMitophagy in neurodegeneration and aging
Fivenson, E. M., Lautrup, S., Sun, N., Scheibye-Knudsen, M., Stevnsner, T., Nilsen, H., Bohr, V. A., & Fang, E. F. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.007 · Cited by 364
PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
Dawicki-McKenna, J. M., Langelier, M.-F., DeNizio, J. E., Riccio, A. A., Cao, C. D., Karch, K. R., McCauley, M., Steffen, J. D., Black, B. E., & Pascal, J. M. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.013 · Cited by 340
“H415 forms part of the conserved PARP family triad H-Y-E (Gibson and Kraus, 2012), which collectively contribute to the PARP NAD binding site based on the related diphtheria toxin structure determined in complex with substrate NAD (Bell and Eisenberg, 1996); there are no structures available for PARP family members bo…”
BackgroundInfluentialPoly (ADP-Ribose) Polymerase Inhibitors: Recent Advances and Future Development
Scott, C. L., Swisher, E. M., & Kaufmann, S. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.8848 · Cited by 355
The comings and goings of PARP-1 in response to DNA damage
Pascal, J. M. (2018) · DNA Repair · doi:10.1016/j.dnarep.2018.08.022 · Cited by 335
Serine ADP-ribosylation depends on HPF1
Bonfiglio, J. J., Fontana, P., Zhang, Q., Colby, T., Gibbs-Seymour, I., Atanassov, I., Bartlett, E., Zaja, R., Ahel, I., & Matic, I. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.003 · Cited by 352
“PARPs are best understood for their roles in DNA damage response and the regulation of chromatin structure and transcription (Gibson and Kraus, 2012; Martin-Hernandez et al., 2016).”
BackgroundChemical reporters for biological discovery
Grammel, M., & Hang, H. C. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1296 · Cited by 342
Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
Li, M., & Yu, X. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.025 · Cited by 321
Vyas, S., Chesarone-Cataldo, M., Todorova, T., Huang, Y.-H., & Chang, P. (2013) · Nature Communications · doi:10.1038/ncomms3240 · Cited by 317
“…of localization and function of subfamily members demonstrates the importance of these functional domains and suggest that in addition to previously described roles in regulation of PARP enzymatic activity 53,54 they can target PARPs to specific cellular locations (Figure 1A and Table 1).”
ADP‐ribosyltransferases, an update on function and nomenclature
Lüscher, B., Ahel, I., Altmeyer, M., Ashworth, A., Bai, P., Chang, P., Cohen, M., Corda, D., Dantzer, F., Daugherty, M. D., et al. (2022) · The FEBS Journal · doi:10.1111/febs.16142 · Cited by 305
“The majority of mammalian proteins that belong to clade 1 are referred to as PARPs and tankyrases (TNKS) or together as ARTDs (see below for definitions), which are located intracellularly [1,4,7,8,21].”
BackgroundSelf-citationFunctions of PARylation in DNA Damage Repair Pathways
Wei, H., & Yu, X. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.05.001 · Cited by 296
“However, most of them are only able to transfer single mono(ADP-ribose) (MAR) group onto their target proteins [5,15].”
BackgroundInfluentialChemistries of bifunctional PROTAC degraders
Cao, C., He, M., Wang, L., He, Y., & Rao, Y. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00220e · Cited by 313
Deficiency of terminal ADP‐ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
Sharifi, R., Morra, R., Denise Appel, C., Tallis, M., Chioza, B., Jankevicius, G., Simpson, M. A., Matic, I., Ozkan, E., Golia, B., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.51 · Cited by 304
“…of the PARP family have been identified in humans (Gibson and Kraus, 2012), and some of these proteins (PARP1, PARP2, and tankyrases) can subsequently add additional ADP-ribose units through glycosidic ribose-ribose bonds to generate a PAR chain (D’Amours et al , 1999; Gibson and Kraus, 2012).”
Insights into the biogenesis, function, and regulation of ADP-ribosylation
Cohen, M. S., & Chang, P. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2568 · Cited by 307
Poly(ADP-ribose) polymerases in double-strand break repair: Focus on PARP1, PARP2 and PARP3
Beck, C., Robert, I., Reina-San-Martin, B., Schreiber, V., & Dantzer, F. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.07.003 · Cited by 302
Epigenetic regulation of the histone-to-protamine transition during spermiogenesis
Bao, J., & Bedford, M. T. (2016) · Reproduction · doi:10.1530/rep-15-0562 · Cited by 274
“PARylation has been functionally linked to a broad array of signaling pathways that affect gene expression, RNA and protein localization, and the maintenance of heterochromatin (Hassa & Hottiger 2008, Gibson & Kraus 2012, Dantzer & Santoro 2013).”
BackgroundChemotherapy induced DNA damage response: Convergence of drugs and pathways
Woods, D., & Turchi, J. J. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.23761 · Cited by 296
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
Gerratana, L., Basile, D., Buono, G., De Placido, S., Giuliano, M., Minichillo, S., Coinu, A., Martorana, F., De Santo, I., Del Mastro, L., et al. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.06.005 · Cited by 285
Regulation of Stem Cell Aging by Metabolism and Epigenetics
Ren, R., Ocampo, A., Liu, G.-H., & Izpisua Belmonte, J. C. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.019 · Cited by 268
PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Kim, D.-S., Camacho, C. V., Nagari, A., Malladi, V. S., Challa, S., & Kraus, W. L. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.020 · Cited by 260
“PARP-1 is a ubiquitously expressed nuclear enzyme that plays key roles in DNA repair and gene regulation (Gibson and Kraus, 2012; Gupte et al., 2017; Krishnakumar and Kraus, 2010).”
BackgroundSelf-citationReaders of poly(ADP-ribose): designed to be fit for purpose
Teloni, F., & Altmeyer, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1383 · Cited by 247
“However, more recently also other functions of PARylation have emerged, including roles in DNA replication, transcription and RNA processing (13,14).”
BackgroundPARP-1 and gene regulation: Progress and puzzles
Kraus, W. L., & Hottiger, M. O. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.005 · Cited by 261
“Z and macroH2A (Gibson and Kraus, 2012).”
BackgroundSelf-citationLüscher, B., Bütepage, M., Eckei, L., Krieg, S., Verheugd, P., & Shilton, B. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00122 · Cited by 255
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Zhu, H., Wei, M., Xu, J., Hua, J., Liang, C., Meng, Q., Zhang, Y., Liu, J., Zhang, B., Yu, X., et al. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01167-9 · Cited by 252
Barkauskaite, E., Jankevicius, G., & Ahel, I. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.007 · Cited by 247
Molecular mechanisms of regulated necrosis
Galluzzi, L., Kepp, O., Krautwald, S., Kroemer, G., & Linkermann, A. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.02.006 · Cited by 258
Zhu, Y., Liu, X., Ding, X., Wang, F., & Geng, X. (2019) · Biogerontology · doi:10.1007/s10522-018-9769-1 · Cited by 255
The expanding universe of PARP1-mediated molecular and therapeutic mechanisms
Huang, D., & Kraus, W. L. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.021 · Cited by 251
Self-citationCrosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes
Cantó, C., Sauve, A. A., & Bai, P. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2013.01.004 · Cited by 246
Combined PARP Inhibition and Immune Checkpoint Therapy in Solid Tumors
Peyraud, F., & Italiano, A. (2020) · Cancers · doi:10.3390/cancers12061502 · Cited by 242
“Thereafter DNA-damage restore, autoPARylation occur that rapidly dissociate PARP from damage site [41].”
BackgroundSerine ADP-ribosylation reversal by the hydrolase ARH3
Fontana, P., Bonfiglio, J. J., Palazzo, L., Bartlett, E., Matic, I., & Ahel, I. (2017) · eLife · doi:10.7554/elife.28533 · Cited by 231
“However, several PARP family members such as PARP1, PARP2, and Tankyrases can generate long chains of the repeating ADP-ribose units on their protein targets (poly-ADPr; PAR; PARylation) (D’Amours et al., 1999; Gibson and Kraus, 2012).”
Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma
Rosellini, M., Marchetti, A., Mollica, V., Rizzo, A., Santoni, M., & Massari, F. (2023) · Nature Reviews Urology · doi:10.1038/s41585-022-00676-0 · Cited by 240
Role of BRCA Mutations in Cancer Treatment with Poly(ADP-ribose) Polymerase (PARP) Inhibitors
Faraoni, I., & Graziani, G. (2018) · Cancers · doi:10.3390/cancers10120487 · Cited by 232
“functions, such as DNA duplication and transcription, and are of great importance in DNA damage response and cell death [16].”
BackgroundRonson, G. E., Piberger, A. L., Higgs, M. R., Olsen, A. L., Stewart, G. S., McHugh, P. J., Petermann, E., & Lakin, N. D. (2018) · Nature Communications · doi:10.1038/s41467-018-03159-2 · Cited by 221
Metabolic regulation of transcription through compartmentalized NAD + biosynthesis
Ryu, K. W., Nandu, T., Kim, J., Challa, S., DeBerardinis, R. J., & Kraus, W. L. (2018) · Science · doi:10.1126/science.aan5780 · Cited by 236
Self-citationAllosteric activation of the RNF146 ubiquitin ligase by a poly(ADP-ribosyl)ation signal
DaRosa, P. A., Wang, Z., Jiang, X., Pruneda, J. N., Cong, F., Klevit, R. E., & Xu, W. (2015) · Nature · doi:10.1038/nature13826 · Cited by 229
Targeting tumour-supportive cellular machineries in anticancer drug development
Dobbelstein, M., & Moll, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4201 · Cited by 229
Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics
Hottiger, M. O. (2015) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-034506 · Cited by 229
Mashimo, M., Onishi, M., Uno, A., Tanimichi, A., Nobeyama, A., Mori, M., Yamada, S., Negi, S., Bu, X., Kato, J., et al. (2021) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014479 · Cited by 227
“(4) AIF is translocated to the nucleus where it induces large-scale DNA fragmentation by DNAase, resulting in cell death.”
BackgroundMacrodomains: Structure, Function, Evolution, and Catalytic Activities
Rack, J. G. M., Perina, D., & Ahel, I. (2016) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060815-014935 · Cited by 217
Undercover: gene control by metabolites and metabolic enzymes
van der Knaap, J. A., & Verrijzer, C. P. (2016) · Genes & Development · doi:10.1101/gad.289140.116 · Cited by 214
“The PARP family is composed of 17 members that are involved in processes such asDNA repair, gene expression, and RNA regulation (Gibson and Kraus 2012; Bock et al. 2015).”
BackgroundOpportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases
Berger, N. A., Besson, V. C., Boulares, A. H., Bürkle, A., Chiarugi, A., Clark, R. S., Curtin, N. J., Cuzzocrea, S., Dawson, T. M., Dawson, V. L., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.13748 · Cited by 212
“PARylation – the modification of a growing number of cellular proteins by PAR units (Pic et al., 2011; Gibson and Kraus, 2012; Krietsch et al., 2013; Ji and Tulin, 2013; Li and Chen, 2014; Gibson et al., 2016) – is now recognized as an important posttranslational modification that extends beyond…”
PARP inhibitor combination therapy
Dréan, A., Lord, C. J., & Ashworth, A. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.10.010 · Cited by 212
Fang, H., Peng, B., Ong, S. Y., Wu, Q., Li, L., & Yao, S. Q. (2021) · Chemical Science · doi:10.1039/d1sc01359a · Cited by 203
Khan, N., Bharali, D. J., Adhami, V. M., Siddiqui, I. A., Cui, H., Shabana, S. M., Mousa, S. A., & Mukhtar, H. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt321 · Cited by 212
Molecular crosstalk between apoptosis, necroptosis, and survival signaling
Vanden Berghe, T., Kaiser, W. J., Bertrand, M. J., & Vandenabeele, P. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.975093 · Cited by 205
Organelle-Specific Initiation of Autophagy
Sica, V., Galluzzi, L., Bravo-San Pedro, J. M., Izzo, V., Maiuri, M. C., & Kroemer, G. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.021 · Cited by 205
“Interestingly, nutrient deprivation has also been shown to cause DNA damage upon the overgeneration of ROS, and PARP1-deficient cells deprived of nutrients mount delayed autophagic responses (Rodrı́guez-Vargas et al., 2012).”
BackgroundInfluentialThe Promise of Proteomics for the Study of ADP-Ribosylation
Daniels, C. M., Ong, S.-E., & Leung, A. K. L. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.012 · Cited by 197
The Toxin-Antitoxin System DarTG Catalyzes Reversible ADP-Ribosylation of DNA
Jankevicius, G., Ariza, A., Ahel, M., & Ahel, I. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.014 · Cited by 200
“ADP-ribosylation regulates many processes in eukaryotes (Barkauskaite et al., 2015; Gibson and Kraus, 2012), and recent studies suggest this modification might play important roles in bacterial metabolism (de Souza and Aravind, 2012; Perina et al.”
BackgroundMuvarak, N. E., Chowdhury, K., Xia, L., Robert, C., Choi, E. Y., Cai, Y., Bellani, M., Zou, Y., Singh, Z. N., Duong, V. H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.002 · Cited by 201
“, 2004), working through catalyzing poly-ADP-ribosylation (PARylation) of itself, histones, and other target proteins (Gibson and Kraus, 2012).”
BackgroundMcPherson, R. L., Abraham, R., Sreekumar, E., Ong, S.-E., Cheng, S.-J., Baxter, V. K., Kistemaker, H. A. V., Filippov, D. V., Griffin, D. E., & Leung, A. K. L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621485114 · Cited by 191
Poly(ADP-ribose): An organizer of cellular architecture
Leung, A. K. L. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402114 · Cited by 193
“This post-translational modification is added to proteins by ADP-ribosyltransferases, commonly known as poly(ADP-ribose) polymerases (PARPs; Hottiger et al., 2010; Gibson and Kraus, 2012).”
BackgroundInfluentialDistribution of protein poly(ADP-ribosyl)ation systems across all domains of life
Perina, D., Mikoč, A., Ahel, J., Ćetković, H., Žaja, R., & Ahel, I. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.05.003 · Cited by 183
“chemical properties of target proteins and controls many important cellular processes such as DNA repair, transcription, regulation of centromere function, telomere length and ageing, protein degradation, apoptosis and necrosis [1,2].”
BackgroundMitochondrial Stress Response and Cancer
O’Malley, J., Kumar, R., Inigo, J., Yadava, N., & Chandra, D. (2020) · Trends in Cancer · doi:10.1016/j.trecan.2020.04.009 · Cited by 188
Transcriptional Roles of PARP1 in Cancer
Schiewer, M. J., & Knudsen, K. E. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0672 · Cited by 186
“The PARP family of enzymes contains 18 family members, PARP1 being the first to be characterized (3), which PARylate client proteins using NADþ as a cofactor, and thereby control a diverse set of biologic functions (4).”
BackgroundPARP Inhibition in Cancer: An Update on Clinical Development
Sachdev, E., Tabatabai, R., Roy, V., Rimel, B. J., & Mita, M. M. (2019) · Targeted Oncology · doi:10.1007/s11523-019-00680-2 · Cited by 179
Priante, G., Gianesello, L., Ceol, M., Del Prete, D., & Anglani, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143598 · Cited by 180
“Several other specialized forms of regulated necrosis have been described, however, such as ferroptosis [16], pyroptosis [17], parthanatos [18,19], mitochondrial permeability transition-dependent regulated necrosis (MPT-RN) [20], pyronecrosis [21,22], and NETosis, a process based on the rapid release of so-called neut…”
BackgroundFOXM1 (Forkhead box M1) in Tumorigenesis
(2013) · Advances in Cancer Research · doi:10.1016/b978-0-12-407190-2.00016-2 · Cited by 184
Induction of apoptosis in MDA-MB-231 breast cancer cells by a PARP1-targeting PROTAC small molecule
Zhao, Q., Lan, T., Su, S., & Rao, Y. (2019) · Chemical Communications · doi:10.1039/c8cc07813k · Cited by 176
Larsen, S. C., Hendriks, I. A., Lyon, D., Jensen, L. J., & Nielsen, M. L. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.07.083 · Cited by 178
“ARTDs/PARPs are known as crucial enzymes in biological processes related to cancer development (Gibson and Kraus, 2012; Schreiber et al., 2006), with PARP inhibitors emerging as promising anticancer agents and commonly used in the clinic for treatment of ovarian and breast cancer (Lord and Ashworth, 2017; Pommier et a…”
BackgroundRapid Evolution of PARP Genes Suggests a Broad Role for ADP-Ribosylation in Host-Virus Conflicts
Daugherty, M. D., Young, J. M., Kerns, J. A., & Malik, H. S. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004403 · Cited by 175
“(1)PARPs are categorized as either poly-ADP-ribosyltransferases (Poly-), mono-ADP-ribosyltransferases (Mono-) or inactive based on presence of conserved motifs and, when available, data using enzymatic assays [4,6].”
BackgroundNew PARP targets for cancer therapy
Vyas, S., & Chang, P. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3748 · Cited by 176
The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response
Li, M., Lu, L.-Y., Yang, C.-Y., Wang, S., & Yu, X. (2013) · Genes & Development · doi:10.1101/gad.226357.113 · Cited by 164
Robu, M., Shah, R. G., Petitclerc, N., Brind’Amour, J., Kandan-Kulangara, F., & Shah, G. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209507110 · Cited by 177
“(i) The PARylated PARP-1 or free PAR chains could serve as a scaffold on which PARylated DDB2 can interact with XPC, such as that suggested for their role with X-ray repair cross-complementing protein 1 (XRCC-1) in the base excision repair (21).”
BackgroundInfluentialEssential Role of Histone Replacement and Modifications in Male Fertility
Wang, T., Gao, H., Li, W., & Liu, C. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00962 · Cited by 158
Viral Macro Domains Reverse Protein ADP-Ribosylation
Li, C., Debing, Y., Jankevicius, G., Neyts, J., Ahel, I., Coutard, B., & Canard, B. (2016) · Journal of Virology · doi:10.1128/jvi.00705-16 · Cited by 166
Boosting NAD+ with a small molecule that activates NAMPT
Gardell, S. J., Hopf, M., Khan, A., Dispagna, M., Hampton Sessions, E., Falter, R., Kapoor, N., Brooks, J., Culver, J., Petucci, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11078-z · Cited by 169
Regulation of NF-κB signalling by the mono-ADP-ribosyltransferase ARTD10
Verheugd, P., Forst, A. H., Milke, L., Herzog, N., Feijs, K. L. H., Kremmer, E., Kleine, H., & Lüscher, B. (2013) · Nature Communications · doi:10.1038/ncomms2672 · Cited by 160
“α-GST 10% Input GST-ARTD10(600–868) GST-ARTD10(600–868)-ΔUIM K48 Ub(2-7) K63 Ub(2-7) + − − + − − + − − − + − − + − − + − − − + − − + − − + mono Ub”
The ways and means that fine tune Sirt1 activity
Revollo, J. R., & Li, X. (2013) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.12.004 · Cited by 160
Metadata
- Authors
- Gibson, B. A., & Kraus, W. L.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Kraus, W. Lee
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-06-20
- Volume
- 13
- Issue
- 7
- Pages
- 411-424
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W1965006127
- Cited by
- 1,226
- References
- 128
- Citations by year
- 2026: 58 · 2025: 79 · 2024: 76 · 2023: 84 · 2022: 94 · 2021: 113 · 2020: 108 · 2019: 83 · 2018: 97 · 2017: 94 · 2016: 86 · 2015: 91 · 2014: 77 · 2013: 79 · 2012: 7
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Keywords
- poly(ADP-ribosyl)ation, poly(ADP-ribose), PARP1, PARP2, PARP family, protein modification, signal transduction, gene expression regulation, PARP inhibitors
- MeSH terms
- Animals, Catalysis, Cell Nucleus, Cherubism, Cytoplasm, Gene Expression Regulation, Humans, Models, Molecular, Poly Adenosine Diphosphate Ribose, Poly(ADP-ribose) Polymerases, Polymers, Protein Conformation, Protein Processing, Post-Translational, RNA, Signal Transduction, Protein Structure, Tertiary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.